Our data demonstrating that PD-1 has a functional role in ILCs within human cSCC tumors suggest that ILCs may play a role in antitumor immunity in cSCC patients with PD-1 controlling this population. The gene discussed is PDCD1; the disease is skin squamous cell carcinoma.